The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer
Use este enlace para citar
http://hdl.handle.net/2183/37241
A non ser que se indique outra cousa, a licenza do ítem descríbese como Atribución 4.0 Internacional
Coleccións
- GI-EXPRELA - Artigos [28]
Metadatos
Mostrar o rexistro completo do ítemTítulo
The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate CancerAutor(es)
Data
2024-03-07Cita bibliográfica
Salamini-Montemurri, M.; Vizoso-Vázquez, Á.; Barreiro-Alonso, A.; Lorenzo-Catoira, L.; Rodríguez-Belmonte, E.; Cerdán, M.-E.; Lamas-Maceiras, M. The Effect of HMGB1 and HMGB2 on Transcriptional Regulation Differs in Neuroendocrine and Adenocarcinoma Models of Prostate Cancer. Int. J. Mol. Sci. 2024, 25, 3106. https://doi.org/10.3390/ijms25063106
Resumo
[Abstract] Human high-mobility group-B (HMGB) proteins regulate gene expression in prostate cancer (PCa), a leading cause of oncological death in men. Their role in aggressive PCa cancers, which do not respond to hormonal treatment, was analyzed. The effects of HMGB1 and HMGB2 silencing upon the expression of genes previously related to PCa were studied in the PCa cell line PC-3 (selected as a small cell neuroendocrine carcinoma, SCNC, PCa model not responding to hormonal treatment). A total of 72% of genes analyzed, using pre-designed primer panels, were affected. HMGB1 behaved mostly as a repressor, but HMGB2 as an activator. Changes in SERPINE1, CDK1, ZWINT, and FN1 expression were validated using qRT-PCR after HMGB1 silencing or overexpression in PC-3 and LNCaP (selected as an adenocarcinoma model of PCa responding to hormonal treatment) cell lines. Similarly, the regulatory role of HMGB2 upon SERPINE1, ZWINT, FN1, IGFPB3, and TYMS expression was validated, finding differences between cell lines. The correlation between the expression of HMGB1, HMGB2, and their targets was analyzed in PCa patient samples and also in PCa subgroups, classified as neuroendocrine positive or negative, in public databases. These results allow a better understanding of the role of HMGB proteins in PCa and contribute to find specific biomarkers for aggressive PCa.
Palabras chave
HMGB proteins
SERPINE1
ZWINT
FN1
IGBPB3
TYMS
CDK1
Neuroendocrine prostatic cancer
Transcriptional regulation
SERPINE1
ZWINT
FN1
IGBPB3
TYMS
CDK1
Neuroendocrine prostatic cancer
Transcriptional regulation
Descrición
This article belongs to the Special Issue Recent Molecular Biology on Ovarian Cancer and Prostate Cancer
Versión do editor
Dereitos
Atribución 4.0 Internacional
ISSN
1422-0067